Table 2. Subsequent risks of senile cataract in MGUS, MM, Waldenström, and AL amyloidosis patients.

	MGUS				MM				Waldenström				AL amyloidosis
	O	SIR	95% CI		O	SIR	95% CI		O	SIR	95% CI		O	SIR	95% CI
All	1711	1.80	1.71	1.88	891	1.70	1.59	1.81	237	1.85	1.63	2.11	338	2.31	2.07	2.57
Gender
Men	771	1.80	1.67	1.93	439	1.80	1.64	1.98	132	1.91	1.60	2.27	161	2.50	2.13	2.92
Women	940	1.80	1.68	1.91	452	1.61	1.46	1.76	105	1.78	1.46	2.16	177	2.16	1.85	2.50
Age at diagnosis (years)
<60	32	2.04	1.40	2.89	30	3.17	2.14	4.53	5	3.31	1.04	7.79	40	7.30	5.21	9.95
60–79	967	1.88	1.76	2.00	536	1.77	1.63	1.93	137	2.10	1.77	2.49	215	2.29	1.99	2.62
80+	712	1.68	1.56	1.81	325	1.53	1.37	1.71	95	1.55	1.26	1.90	83	1.77	1.41	2.19
Subtype
Senile incipient cataract (H25.0)	282	1.80	1.59	2.02	151	1.64	1.39	1.93	43	1.93	1.40	2.60	61	2.59	1.98	3.33
Senile nuclear cataract (H25.1)	111	1.75	1.44	2.11	53	1.45	1.08	1.89	16	1.70	0.97	2.76	15	1.70	0.95	2.81
Other senile cataract (H25.2, H25.8)	28	1.88	1.25	2.71	20	2.11	1.29	3.26	3	1.36	0.26	4.02	10	4.20	2.00	7.76
Senile cataract, unspecified (H25.9)	1290	1.80	1.70	1.90	667	1.73	1.60	1.86	175	1.86	1.60	2.16	252	2.26	1.99	2.56

MGUS: Monoclonal gammopathy of undetermined significance; MM: Multiple myeloma.

O = Observed cases; SIR = Standardized incidence ratio; CI = Confidence intervals.

Bold type: 95% confidence interval does not include 1.00.